Esophageal Diseases Clinical Trial
Official title:
Study of Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy
Magnetically controlled capsule endoscopy (MCCE) is an outstanding opportunity for the painless endoscopic screening of the esophagus and stomach before small bowel examiantion. Further improvement in patients positioning might increase the esophageal transit time of the capsule endoscope and could improve the sensitivity and specificity of the esophageal MCCE investigation. Our present study aimed to compare the visualization of the esophagus (especially the Z-line) with different capsule swallowing protocols.
Magnetic controlled capsule endoscope (MCCE) systems have been developed over the last 10-15 years to examine the upper GI tract, particularly the stomach. The new Navicam MACE system consists of a magnetic capsule endoscope, an external control magnet, a data recording kit and a computer workstation. With the appropriate software, allows real-time tracking and monitoring of the capsule inside the body. This method may in the near future be an optimal non-invasive method for screening gastric cancer and Barrett's oesophagus in high-risk populations. Esophagogastroduodenoscopy (EGD) is the gold standard diagnostic test, however it is very inconvenient for patients without sedation. The aim of our present study was a feasibility study to evaluate the safety and efficacy of Ankon MCCE for the investigation of esophageal abnormalities in patients referred for small bowel capsule endoscopy in our endoscopy department, to develop and test a method to use MCCE for esophageal examination, and to analyze the visualization of esophageal mucosa with our newly developed capsule swallowing protocol and manual capsule maneuvering. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05054933 -
Ultrasound Capsule Endoscopy for Esophagus Examination
|
N/A | |
| Completed |
NCT04090554 -
Cytosponge™ Feasibility Study in Tanzania
|
N/A | |
| Active, not recruiting |
NCT03962179 -
Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)
|
N/A | |
| Completed |
NCT03549494 -
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
|
Phase 2 | |
| Recruiting |
NCT04481100 -
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
|
Phase 2 | |
| Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
| Completed |
NCT00977678 -
Drop in Gastroscopy - Experience After 9 Months
|
N/A | |
| Completed |
NCT00874263 -
Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies
|
N/A | |
| Terminated |
NCT00442507 -
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
|
Phase 2 | |
| Recruiting |
NCT03832959 -
Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study.
|
N/A | |
| Withdrawn |
NCT02569073 -
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
|
Phase 4 | |
| Recruiting |
NCT05252078 -
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
|
Phase 2 | |
| Recruiting |
NCT00260585 -
Esophageal Cancer Risk Registry
|
||
| Completed |
NCT03187314 -
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
|
Phase 2 | |
| Recruiting |
NCT05004155 -
Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
|
||
| Recruiting |
NCT05469152 -
Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases
|
N/A | |
| Recruiting |
NCT05877300 -
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement
|
Phase 1 | |
| Recruiting |
NCT03267355 -
Indications and Outcomes of Endoscopic Ultrasound in Tanta
|
N/A | |
| Recruiting |
NCT05311787 -
The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery
|
N/A | |
| Recruiting |
NCT00939263 -
Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
|
N/A |